Center for Health Care Strategies: Telehealth and Medications for Opioid Use Disorder: Evidence Roundup
In the face of an overwhelming overdose crisis, largely driven by the rise in the synthetic opioid fentanyl, telehealth for MOUD treatment promises to benefit many people. Currently, prescription volumes for MOUD are low and certain under-resourced communities experience significant disparities in accessing this treatment. Emerging evidence indicates strong levels of patient satisfaction, retention rates similar to that of in-person treatment, and high rates of adherence to buprenorphine. This blog post reviews evidence and implementation resources with emerging state and federal policies to help enhance services for people with complex needs.